Market Performance - The brain-computer interface concept declined by 1.40%, ranking among the top declines in concept sectors, with major declines seen in Rongtai Health, Beiqing Song, and Innovation Medical [1] - The top gainers in the sector included Jihua Group, Dongfang Zhongke, and Yanshan Technology, which rose by 1.57%, 0.38%, and 0.37% respectively [1] Concept Sector Overview - The leading concept sectors for the day included: - Military Equipment Restructuring: +8.73% - Electronic ID: +2.89% - Domestic Aircraft Carrier: +2.19% - Military Informationization: +2.05% - Brain-Computer Interface: -1.40% [2] Fund Flow Analysis - The brain-computer interface sector experienced a net outflow of 940 million yuan, with 27 stocks seeing net outflows, and 5 stocks exceeding 50 million yuan in outflows [2] - The stock with the highest net outflow was ST Huatuo, with a net outflow of 309 million yuan, followed by Hanwei Technology, Innovation Medical, and Tom Cat with net outflows of 109 million yuan, 63 million yuan, and 58 million yuan respectively [2] Individual Stock Performance - The stocks with the highest net outflows in the brain-computer interface sector included: - ST Huatuo: -2.51%, turnover rate 2.25%, net outflow 30.89 million yuan - Hanwei Technology: -2.03%, turnover rate 11.85%, net outflow 10.94 million yuan - Innovation Medical: -4.28%, turnover rate 17.95%, net outflow 6.31 million yuan [3]

Investment Rating - The report maintains a "Recommend" rating for the healthcare industry [7] Core Insights - The pharmaceutical sector underperformed the CSI 300 index, with the Shenwan Pharmaceutical Bio Index declining by 4.35% from June 16 to June 20, 2025, lagging behind the CSI 300 by 3.90 percentage points, ranking 29th among 31 Shenwan first-level industry indices [2][12] - Year-to-date, the Shenwan Pharmaceutical Bio Index has increased by 4.57%, outperforming the CSI 300 by 6.81 percentage points, ranking 6th among the 31 indices [2][14] - As of June 20, 2025, the valuation of the pharmaceutical sector stands at 27.07 times (TTM overall method, excluding negative values), with a premium of 140.87% compared to the CSI 300 [2][17] Summary by Sections Market Performance - The pharmaceutical sector's performance from June 16 to June 20, 2025, showed a decline of 4.35%, underperforming the CSI 300 index [12] - The sector's valuation as of June 20, 2025, is 27.07 times, indicating a significant premium over the CSI 300 [17] Key Events - On June 20, 2025, the National Medical Products Administration (NMPA) held a meeting to discuss measures to support the innovation of high-end medical devices, which includes optimizing special approval processes and enhancing communication and guidance mechanisms [4][21] Industry Perspective - The high-end medical device market in China is expanding, with significant growth in areas such as medical robots, high-end medical imaging equipment, AI medical devices, and new biomaterials [5][22] - The upcoming measures from the NMPA are expected to facilitate the transformation of research achievements into practical products, meeting clinical needs and providing market opportunities for companies [5][22] - The report expresses optimism about innovative drugs, overseas expansion, and the clearing of procurement segments, suggesting a focus on insulin, orthopedics, and certain generic drug companies [5][22]

Investment Rating - The report does not explicitly state an investment rating for the industry, but it highlights potential opportunities in high-end medical devices due to favorable regulatory changes [2]. Core Insights - The pharmaceutical and biotechnology sector experienced a significant decline of 4.35% from June 16 to June 20, underperforming compared to the Shanghai and Shenzhen 300 index, which fell by 0.45% [2][7]. - High-end medical devices are poised for growth following the approval of regulatory measures aimed at supporting innovation in this area, including medical robots and AI medical devices [2][10]. - The ADA conference from June 21 to 24 is showcasing advancements in obesity medications, with a focus on oral drugs and multi-target approaches, particularly highlighting Eli Lilly's clinical data [2][10]. Market Weekly Review - The pharmaceutical and biotechnology sector saw a broad decline, with sub-sectors such as other biological products, medical research outsourcing, and chemical preparations leading the downturn [2][7]. - Notable stock performances included a rise of 21.2% for Anglikang and a drop of 16.7% for Aoyang Health [10]. Industry News and Key Company Announcements - Regulatory measures to support high-end medical device innovation were approved, which include optimizing special approval processes and enhancing post-market surveillance [2][10]. - Eli Lilly's GLP-1 small molecule agonist, with promising clinical data, is under scrutiny at the ADA conference [10]. - Recent approvals and clinical trial advancements were reported by various companies, including CanSino and WuXi Biologics, indicating ongoing innovation in the sector [12][13].

胡盛寿在致辞时表示，作为长三角生物医药创新枢纽，苏州是创新产业集聚的高地，是我国生物医 药产业发展的成功样板和高端医疗器械创新研发的前沿阵地，吸引着新一代年轻的科技创新人才。本届 中国生物医学工程大会鼓励青年学者展示才能和成果，致力于成为青年创新人才脱颖而出的舞台。期待 中国生物医学工程学会与苏州市未来能携手合作、协力共进，在人才培养、技术研发、成果转化方面打 造地方与学会合作的典范，共同助力生物医药产业的创新腾飞。 昨天（6月21日），2025中国生物医学工程大会暨创新医疗峰会开幕式在苏州举行。中国工程院院 士、中国生物医学工程学会理事长胡盛寿，中国科学院院士、候任理事长骆清铭，市委副书记、市长吴 庆文，中国科学院院士程和平、顾宁出席开幕式。 副市长季晶出席。 作为中国生物医学工程学会主办的品牌学术会议，中国生物医学工程大会暨创新医疗峰会秉承"医 工融合发展，创新引领未来"主题，聚焦生物医学工程重点领域和关键技术，以推进国产医疗器械自主 创新为使命，已成功举行6届。本次大会紧密围绕人工智能，深度聚焦智能医疗、智慧健康等前沿领 域，特别关注纳米医学、类器官与器官芯片、再生医学与干细胞治疗、医学影像、医疗机器人 ...

今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | PET铜箔 | 2.09 | 可燃冰 | -4.14 | | 光刻胶 | 1.45 | 脑机接口 | -3.34 | | BC电池 | 1.13 | 短剧游戏 | -3.07 | | 钙钛矿电池 | 1.06 | 智谱AI | -3.06 | | 航运概念 | 1.02 | 快手概念 | -2.99 | | 白酒概念 | 0.83 | MLOps概念 | -2.97 | | 兵装重组概念 | 0.80 | 华为盘古 | -2.80 | | 先进封装 | 0.79 | 财税数字化 | -2.79 | | 石墨电极 | 0.65 | 云办公 | -2.66 | | 低辐射玻璃(Low-E) | 0.64 | 小红书概念 | -2.53 | 资金面上看，今日脑机接口概念板块获主力资金净流出5.46亿元，其中，23股获主力资金净流出，7股 主力资金净流出超3000万元，净流出资金居首的是汉威科技，今日主力资金净流出1.33亿元，净流出资 金居前的还有创新医疗、汤姆猫、诚 ...

| | 龙 龙虎榜 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | 科力股份 7.67% | 金橙子 5.90% | 退市龙宇 4.02% | 退市海越 -6.67% | 退市鵬博 -5.56% | 邦島科技 -3.91% | 标准股 | | | 洲际油气 5.43% | 金牛化工 6.26% | 曲美家居 -9.42% | 空港股份 10.05% | 诺德股份 10.12% | 时代出版 10.03% | 泉峰汽车 | | 沪市 | 兴业股份 10.04% | 华脉科技 1.30% | 海阳科技 -8.88% | 江南新材 2.38% | 安德利 -10.00% | 合锻智能 -10.00% | 长江投 | | | 华阳新材 -9.99% | 苏利股份 -9.99% | *ST沐邦 4.74% | 荣泰健康 8.01% | 长城军工 10.02% | 北矿科技 -6.38% | 新光光 | | | 首华燃气 20.00% | 选豪新材 20.02% | 北方长龙 20.01% | 百纳千成 19.92% | 海科新源 2 ...

创新医疗今日涨停，全天换手率31.78%，成交额17.45亿元，振幅13.25%。龙虎榜数据显示，机构净买 入2666.40万元，营业部席位合计净买入1.80亿元。 深交所公开信息显示，当日该股因日涨幅偏离值达11.50%上榜，机构专用席位净买入2666.40万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交4.41亿元，其中，买入成交额为3.24亿 元，卖出成交额为1.17亿元，合计净买入2.07亿元。 具体来看，今日上榜的营业部中，共有1家机构专用席位现身，即买三、卖一，买入金额5869.83万元， 卖出金额3203.43万元，合计净买入2666.40万元。 资金流向方面，今日该股主力资金净流入5.82亿元，其中，特大单净流入5.82亿元，大单资金净流出 17.56万元。近5日主力资金净流入4.12亿元。（数据宝） 创新医疗6月19日交易公开信息 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 国泰海通证券股份有限公司上海长宁区江苏路证券营业 | 8359.75 | 3 ...

| 序号 | 营业部名称 | 买入额(万元) | 卖出额(万元) | 净额(万元) | | --- | --- | --- | --- | --- | | 1 | 国泰海通证券股份有限公司上海长宁区江苏路证券营业部 | 8359.75 | 34.97 | 8324.77 | | 2 | 中泰证券股份有限公司湖北分公司 | 6832.08 | 4.45 | 6827.63 | | 3 | 机构专用 | 5869.83 | 3203.43 | 2666.40 | | ব | 开源证券股份有限公司西安太华路证券营业部 | 5185.79 | 6.79 | 5179.00 | | 5 | 中信证券股份有限公司上海徐汇区港溪北路证券营业部 | 3432.85 | 11.33 | 3421.52 | | | 合计： | 29680.30 | 3260.98 | 26419.32 | 证券之星消息，沪深交易所2025年6月19日公布的交易公开信息显示，创新医疗（002173）因日涨幅偏 离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。 截至2025年6月19日收盘，创新医疗(002173)报收于13.5 ...

医药生物行业资金流入榜 | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- | --- | --- | | 002173 | 创新医疗 | 10.04 | 31.78 | 58181.79 | | 600276 | 恒瑞医药 | -0.44 | 0.59 | 8207.12 | | 002550 | 千红制药 | -1.05 | 11.19 | 7525.42 | | 002826 | 易明医药 | 1.91 | 24.11 | 6926.24 | | 600380 | 健康元 | -0.63 | 0.80 | 3477.83 | | 002793 | 罗欣药业 | -1.05 | 3.22 | 2826.06 | | 688166 | 博瑞医药 | -0.45 | 2.17 | 2795.76 | | 688235 | 百济神州 | -0.39 | 1.51 | 2696.74 | | 688117 | 圣诺生物 | 1.47 | 6.91 | 2654.77 | | 688271 | 联影医疗 | 0.15 | 0.34 | 2 ...

| 股票名称 | 板数 | 涨跌幅 | 涨停时间 | 上涨逻辑 | | --- | --- | --- | --- | --- | | 诺德股份 | 3天3板 | 10.12% | 09:36 | 固态电池 | | 600110 | | | | | | 湘潭电化 | 首板 | 10.05% | 09:30 | 固态电池 | | 002125 | | | | | | 丰元股份 | 首板 | 10.03% | 09:33 | 固态电池 | | 002805 | | | | | | 海科新源 | 首板 | 20.02% | 09:36 | 固态电池 | | 301292 | | | | | | 科恒股份 | | 11.68% | | 固态电池 | | 300340 | | | | +稀土永 | 归因: 国内首个人形机器人全产业链专业展"2025 杭州 国际人形机器人与机器人技术展览会",将于6月 20-22日在杭州举办。 | 股票名称 | 板数 | 涨跌幅 | 涨停时间 | 上涨逻辑 | | --- | --- | --- | --- | --- | | 凯旺科技 | 首板 | 20.01% | 10:30 | 机 ...